檢索結果 - Fabbri LM

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal 由 Vanfleteren L, Fabbri LM, Papi A, Petruzzelli S, Celli B

    發表在 International Journal of COPD (2018-12-01)
    獲取全文
    Article


  2. 2

    Does roflumilast decrease exacerbations in severe COPD patients not controlled by inhaled combination therapy? the REACT study protocol 由 Calverley PM, Martinez FJ, Fabbri LM, Goehring UM, Rabe KF

    發表在 International Journal of COPD (2012-06-01)
    獲取全文
    Article


  3. 3

    Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipro... 由 Price D, Henley W, Cançado JED, Fabbri LM, Kerstjens HA, Papi A, Roche N, Şen E, Singh D, Vogelmeier CF, Nudo E, Carter V, Skinner D, Vella R, Soriano JB, Kots M, Georges G

    發表在 Pragmatic and Observational Research (2024-01-01)
    獲取全文
    Article


檢索工具: